v3.26.3
Composition of Certain Condensed Consolidated Financial Statement Line Items
 9 Months Ended
Sep. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Composition of Certain Condensed Consolidated Financial Statement Line Items Composition of Certain Condensed Consolidated Financial Statement Line Items
Property and Equipment, Net
Property and equipment consisted of the following:
(in thousands)September 30,
2026		December 31,
2025
Laboratory equipment$6,825 $6,531 
Leasehold improvements63 118 
Computer hardware597 542 
Furniture, fixtures and office equipment316 322 
Prototype equipment2,330 2,258 
Construction in progress4,022 1,807 
14,153 11,578 
Less: Accumulated depreciation(8,885)(8,121)
Total$5,268 $3,457 
The Company recorded depreciation expense of $0.2 million and $0.8 million for the three and nine months ended September 30, 2026, and $0.4 million and $1.3 million for the three and nine months ended September 30, 2025, respectively, which was primarily allocated to research and development expense.
Accrued Expenses and Other Liabilities
Accrued expenses and other liabilities consisted of the following:
(in thousands)September 30,
2026		December 31,
2025
Employee compensation$2,397 $2,514 
Accrued research and development
641 221 
Accrued professional and consulting fees
424 259 
Grant liabilities419 — 
Other478 183 
Total$4,359 $3,177 
Cash, Cash Equivalents and Restricted Cash
Cash, cash equivalents and restricted cash consisted of the following:
(in thousands)September 30,
2026		December 31,
2025
Cash and cash equivalents$10,467 $12,388 
Restricted cash included in other long-term assets (Note 8)884 1,002 
Total$11,351 $13,390 
Other long-term assets consisted of $0.9 million of restricted cash and $0.2 million of deposits as of September 30, 2026 and $1.0 million of restricted cash and $0.2 million of deposits as of December 31, 2025.